Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere is no absolute ban on alcohol while taking Wegovy, but the combination deserves serious thought. Semaglutide slows how quickly your stomach empties, which changes how your body processes both food and drink — and official NHS guidance flags alcohol as something to approach cautiously on this treatment. Here is what the evidence actually says, and what our prescribers advise patients who ask.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial (published in the New England Journal of Medicine) randomised 1,961 adults with obesity to semaglutide 2.4 mg or placebo over 68 weeks and reported average weight loss of around 15%. Alcohol was not studied as a primary variable, but participants were not required to abstain. What the trial and post-marketing experience have established is that the most common side effects of semaglutide (nausea, vomiting, reflux and a general sense of gastric pressure) are meaningfully worsened by alcohol. Drinking on an already unsettled stomach accelerates the risk of vomiting and dehydration.
Slower gastric emptying, which is central to how semaglutide works, means alcohol lingers longer before reaching the small intestine. The practical result is that one drink may feel like two. This is not a listed adverse event in the SmPC, but it is consistent with the mechanism and widely reported by patients. Worth knowing before a social occasion.
The NHS semaglutide medicines page advises keeping alcohol intake moderate while taking semaglutide. That framing matters: moderate, not zero. A prescriber is not going to flag an occasional glass of wine as a clinical concern. What they will flag is heavy or regular alcohol use, for two reasons. First, alcohol is an independent risk factor for acute pancreatitis. Semaglutide carries its own infrequent but recognised pancreatitis signal (the MHRA issued a Drug Safety Update on this in January 2026) and combining it with heavy drinking compounds that risk in a way that changes the clinical picture.
Second, Wegovy is licensed for weight management alongside a reduced-calorie diet. Alcohol is calorie-dense and appetite-disinhibiting; consistent heavy use directly undermines the behavioural changes the treatment is designed to support. A prescriber reviewing your progress will weigh this when deciding whether to continue or increase your dose. You can read more about what full eligibility assessment looks like on our overview of who Wegovy is suitable for.
A lot of patients assume that because Wegovy is a prescription medicine, there must be a formal rule along the lines of "no alcohol, full stop." There is not. The SmPC does not list a hard contraindication. What there is instead is a clinical picture that shifts depending on how much you drink and how often. Occasional, moderate drinking alongside semaglutide is not a reason to delay or skip a dose. Wegovy is a once-weekly injection, and if you are wondering whether semaglutide is still safe to use after 28 days, that question has its own dedicated answer worth reading before your next dose. Questions about the timing of food and your injection have their own dedicated answers, such as whether taking Wegovy after eating affects how it works.
Where the picture shifts is if drinking makes your GI side effects significantly worse, or if it becomes frequent enough to affect your overall approach to the lifestyle changes that go alongside treatment. In those situations, the right conversation is with your prescriber, not a forum. A real prescriber (not an automated system) reviews every consultation at our treatment page, and aftercare is available seven days a week precisely for questions like this one.
If you are going to drink, some straightforward steps reduce the chance of a difficult evening. Eating something beforehand matters even more on semaglutide than off it, alcohol absorbed into an already slow-moving stomach hits harder. Stay well hydrated; semaglutide-related nausea combined with alcohol dehydration is an unpleasant combination that can tip into vomiting. Keep the total amount low, at least while you are finding out how you respond. Many people on semaglutide find one drink is genuinely enough, and if you are only looking to shift a small amount of weight, our guide to whether Wegovy is appropriate when you only want to lose around 10 pounds is worth reading before you start.
If you are also taking medicines for type 2 diabetes alongside Wegovy, this adds a layer of care: alcohol can mask the signs of low blood sugar. This is not a Wegovy-specific risk, but your prescriber should know your full medicines list. Wegovy's eligibility criteria and the conditions it is licensed alongside are set out in detail on our BMI and eligibility guide for Wegovy. If you are weighing up the broader picture of what this treatment costs relative to what is included, our guide to Wegovy pricing in the UK explains what a legitimate private prescription should cover. And if you have questions specific to your situation, our support team is available seven days a week.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.